Development and validation of phosphonate-based inhibitors and activity-based probes (ABPs) for detection and pharmacological targeting of kallikreins

The generation of a novel activity-based probe (ABP) and inhibitor specific for kallikrein 7 (KLK7) and validation of its therapeutic effects in vivo is described here. KLK7 is a protease with well-established functions in skin inflammation and overdesquamation and in cancer. ABPs, on the other hand...

Full description

Bibliographic Details
Main Author: Μπισύρης, Ευάγγελος
Other Authors: Bisyris, Evangelos
Language:English
Published: 2021
Subjects:
Online Access:http://hdl.handle.net/10889/15718

Similar Items